USFDA completes inspection at SMS Pharmaceuticals’ API manufacturing facility at Visakhapatnam [Healthcare]
AI Summary1 min read
TL;DR
USFDA has completed an inspection at SMS Pharmaceuticals' API manufacturing facility in Visakhapatnam. The company, a global API manufacturer with multiple facilities and over 600 employees, has grown significantly since 1990.
Tags
Pharmaceuticals & DrugsHealthcare
SMS Pharmaceuticals Ltd. is a global player in API manufacturing having strong research and manufacturing team supported by state of art facilities. What started off as a single facility single product manufacturing company in 1990 grew to be a multi location group having product list spreading across an array of therapeutic segments. SMS is currently a listed company having ever appreciating international and domestic customer base. Having six multi product facilities in operation, one under development, and two research centers, SMS has truly graduated in to big league with more than 600 employees working for it.